Skip to content
Back to Blog
Bio
2026-10-057 min read7

Korea Codifies Medical Device GMP Conformity Recognition — Certificate Revocation, Corrective Orders and the Appointed-Auditor System in Force Since July 1, and How SME Manufacturers and Importers Should Prepare for Periodic Audits

Korea has written medical device GMP conformity audits, certificate revocation and corrective orders, appointed auditors and audit body designation renewal into law, in force since July 1, 2026. This guide covers the findings SME manufacturers and importers face most often and a six-month roadmap for periodic audit preparation.

KITIM Consulting Team

What Changed — GMP Conformity Recognition Moves from Notice to Statute

Korea's medical device GMP conformity recognition was long operated mainly under notices issued by the Ministry of Food and Drug Safety (MFDS). An amendment to the Medical Devices Act (Act No. 21263, promulgated December 30, 2025) now gives a statutory basis to conformity audits, revocation of conformity certificates and corrective orders, and renewal of audit body designations. The amended Enforcement Rule was pre-announced on April 3, 2026 and took effect on July 1. A draft of the related notice, the Regulation on Designation of Institutions Related to Medical Device Manufacturing and Quality Control, was also pre-announced on June 12 (MFDS Public Notice No. 2026-283); check the MFDS notice list for whether it has been issued and taken effect. Three months in, the rules are being applied in actual audits. This article is for medical device manufacturers and importers, not pharmaceutical companies.

Key Change 1 — Explicit Grounds for Revocation and Corrective Orders

  • Revocation: conformity recognition obtained by false or otherwise improper means
  • Corrective order: failures to meet the standard, such as missing quality records or corrective actions left undone
  • Severity of sanctions: check the Enforcement Rule for the specific criteria by type of violation
  • How far the room to remediate a failed periodic audit differs from past practice has to be checked case by case against the Enforcement Rule and MFDS guidance, and it cannot be stated as a blanket rule. With the grounds for sanctions now written into law, though, it is risky to plan on the assumption that findings can simply be fixed afterward. A conformity certificate is a precondition for selling manufactured or imported products, so revocation disrupts shipments of the affected product group along with any pending approval or certification timelines.

    Key Change 2 — Audit Criteria, Procedure and Submissions

    The Enforcement Rule now specifies the submission documents, including the site overview, quality manual, and manufacturing and quality control records, and sets out the basis for on-site inspections. What to prepare depends on the audit type.

  • Initial audit: the quality management system as a whole and evidence that it is actually operating
  • Additional audit: process and testing capability for a new product group
  • Change audit: validation of the change, such as a site relocation
  • Periodic audit: the full operating record of the past three years
  • Key Change 3 — Appointed GMP Auditors and Renewal of Audit Body Designations

    The rules introduce procedures for appointing GMP auditors and cancelling appointments, along with designation and operating standards for training institutions. Quality management audit bodies and technical documentation review bodies are now subject to designation renewal. Once qualifications and training are managed as a formal system, variation between auditors is likely to narrow and the bar to rise. An item that was passed over in a previous audit may not pass the next one.

    A Checklist of Frequent Findings at SME Device Companies

  • Design and risk management mismatch: the risk management file (ISO 14971) does not reflect actual design changes
  • Weak CAPA closure: actions recorded without root cause analysis, or no effectiveness check
  • Supplier and outsourced process control: missing evaluation criteria and re-evaluation records, or no quality agreement for outsourced sterilization or processing
  • Internal audits and management reviews run as a formality: the same conclusions every year, with no follow-up tracking
  • Quality manager: incomplete training evidence and undocumented authority and responsibility
  • A Roadmap Starting Six Months Before the Periodic Audit

  • Six months out: run a clause-by-clause gap analysis and a mock audit to list likely nonconformities.
  • Three months out: fill record gaps and close open CAPAs through effectiveness verification.
  • One month out: assemble the submission package and assign on-site respondents for each process.
  • If you also maintain ISO 13485 certification or MDSAP, a single clause mapping table can tie the documentation together, and one integrated internal audit plan can cover all three and cut duplicated work.

    How KITIM Can Help

    KITIM supports GMP gap assessments, quality manual and procedure updates, and mock audits, and we also review links to government support programs for medical device quality and regulatory work. If a periodic audit is approaching, contact KITIM for a consultation and start with an assessment of where you stand today.

    Medical Device GMPConformity RecognitionCertificate RevocationCorrective OrderGMP AuditorQuality Management Audit BodyMedical Device Act Enforcement RulePeriodic AuditMFDS

    Related Posts

    Bio

    Biologics Approval Fees Rise From KRW 8.03M to 20.71M, Data-Submission Drugs About 6x — MFDS Fee Regulation Amendment Pre-Announced Nov 6, 2026 (Comments Due Nov 26 / Dec 16): Filing Timing, Budget Review and Fee-Reduction Checks for Pharma & Bio SMEs

    Under the fee amendment MFDS proposed on November 6, approval fees for new biologics would rise from KRW 8.03 million to KRW 20.71 million, and fees for data-submission drugs would go up about sixfold. This guide shows pharma and bio SMEs how to review their filing timing, budgets, fee-reduction eligibility and public comments.

    2026-11-09
    Management Consulting

    Factories With 20–49 Workers Will Need a Safety or Health Manager — Korea's First Tripartite Agreement on November 5 (About 30,000 Sites in 5 Industries Including Manufacturing, Decree Amendment in 2027, Target Start 2028), the Owner-Led Alternative and Government Payroll Support: A Preparation Guide for Small Manufacturers

    Under Korea's November 5 tripartite agreement, about 30,000 sites with 20–49 workers in manufacturing and four other industries are expected to need a qualified safety or health manager from 2028. This guide covers what is settled and what is still open, the owner-led alternative, a cost comparison, and a preparation checklist.

    2026-11-09
    Government Programs

    SMEs Can Now Enter the KRW 1,500 Trillion 'Mega Project' Supply Chain from the Design Stage — MSS Joins as a Lead Ministry, Large/Mid-Tier–SME Councils and Regional Councils Launch (Nov 6 Plan to Expand Planning-Stage Participation), and How SMEs Targeting Semiconductor, AI Data Center and Physical AI Supply Chains Should Prepare Validation, Certification and Mass-Production Qualification

    MSS has joined Korea's KRW 1,500 trillion mega projects as a lead ministry and plans to bring SMEs in from the planning stage. This guide covers how the central and regional councils will work and how to line up support programs against the validation, certification and mass-production barriers.

    2026-11-09
    Updated daily

    Let AI find government support programs in this field

    Complete a 3-minute company assessment and we will recommend programs that fit your company, each with a match score. It is free.

    Get AI-Matched Programs for Free

    Need Consulting?

    Our technology innovation consultants will propose the optimal solution for your company.